Among people with type 2 diabetes who received a GLP-1 receptor agonist, there was less correlation between this treatment and thyroid cancer than among people with type 2 diabetes treated with insulin.
Early surgery may benefit patients shown to be at risk for medullary thyroid cancer through genetic screening program, but overall merit of such gene testing remains debatable, say editorialists.
All patients with advanced thyroid disease and most patients with incurable radioiodine refractory differentiated thyroid cancer should undergo somatic mutational testing, say experts.